Timothy W. Yu

Affiliations: 
Harvard Medical School and Broad Institute 
Google:
"Timothy Yu"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

D'Gama AM, Hills S, Douglas J, et al. (2024) Implementation of rapid genomic sequencing in safety-net neonatal intensive care units: protocol for the VIrtual GenOme CenteR (VIGOR) proof-of-concept study. Bmj Open. 14: e080529
Lai J, Demirbas D, Kim J, et al. (2023) ATM-deficiency-induced microglial activation promotes neurodegeneration in ataxia-telangiectasia. Cell Reports. 43: 113622
Zhao B, Nguyen MA, Woo S, et al. (2023) Contribution and therapeutic implications of retroelement insertions in ataxia telangiectasia. American Journal of Human Genetics
Kim J, Woo S, de Gusmao CM, et al. (2023) A framework for individualized splice-switching oligonucleotide therapy. Nature
Vockley J, Aartsma-Rus A, Cohen JL, et al. (2022) Whole-genome sequencing holds the key to the success of gene-targeted therapies. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics
D'Gama AM, Del Rosario MC, Bresnahan MA, et al. (2022) Integrating rapid exome sequencing into NICU clinical care after a pilot research study. Npj Genomic Medicine. 7: 51
Lai A, Soucy A, El Achkar CM, et al. (2022) The ClinGen Brain Malformation Variant Curation Expert Panel: Rules for somatic variants in AKT3, MTOR, PIK3CA, and PIK3R2. Genetics in Medicine : Official Journal of the American College of Medical Genetics
Williams LA, Gerber DJ, Elder A, et al. (2022) Developing antisense oligonucleotides for a mutation-induced, ultra-rare neurological disorder using patient-derived cellular models. Molecular Therapy. Nucleic Acids. 29: 189-203
Yabumoto M, Kianmahd J, Singh M, et al. (2021) Novel variants in KAT6B spectrum of disorders expand our knowledge of clinical manifestations and molecular mechanisms. Molecular Genetics & Genomic Medicine. e1809
Harris HK, Nakayama T, Lai J, et al. (2021) Disruption of RFX family transcription factors causes autism, attention-deficit/hyperactivity disorder, intellectual disability, and dysregulated behavior. Genetics in Medicine : Official Journal of the American College of Medical Genetics
See more...